DNA methylation and miRNA-1296 act in concert to mediate spatiotemporal expression of KPNA7 during bovine oocyte and early embryonic development

doi:10.21203/rs.2.9942/v1

Download PDF

Research article

DNA methylation and miRNA-1296 act in concert to mediate spatiotemporal expression of KPNA7 during bovine oocyte and early embryonic development

https://doi.org/10.21203/rs.2.9942/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 02 Dec, 2019

Read the published version in BMC Developmental Biology →

You are reading this older preprint version

Read the latest preprint version →

Background

Epigenetic regulation of oocyte-specific maternal factors is essential for oocyte and early embryonic development. KPNA7 is an oocyte-specific maternal factor, which controls transportation of nuclear proteins important for early embryonic development. To elucidate the epigenetic mechanisms involved in the controlled expression of KPNA7, both DNA methylation associated transcriptional silencing and miRNA-mediated mRNA degradation of KPNA7 were examined.

Results

Comparison of DNA methylation profiles at the proximal promoter of KPNA7 gene between oocyte and 6 different somatic tissues identified 3 oocyte-specific differentially methylated CpG sites. Expression of KPNA7 mRNA was reintroduced in bovine kidney-derived CCL2 cells after treatment with the methylation inhibitor, 5-aza-2-deoxycytidine (5-Aza). Analysis of the promoter region of KPNA7 gene in CCL2 cells treated with 5-Aza showed a lighter methylation rate in all the CpG sites. Bioinformatic analysis predicted 4 miRNA-1296 binding sites in the coding region of KPNA7 mRNA. Ectopic co-expression of miRNA-1296 and KPNA7 in HEK293 cells led to reduced expression of KPNA7 protein. Quantitative real time PCR analysis revealed that miRNA-1296 is expressed in oocytes and early stage embryos, and the expression reaches a peak level in 8-cell stage embryos, coincident with the time of embryonic genome activation and the start of declining of KPNA7 expression.

Conclusions

These results suggest that DNA methylation may account for oocyte-specific expression of KPNA7, and miRNA-1296 targeting the coding region of KPNA7 is a potential mechanism for KPNA7 transcript degradation during the maternal-to-zygotic transition.

Developmental Biology

DNA methylation

miRNA

oocyte

early embryonic development

maternal

cattle

Successful germ cell development and differentiation during oogenesis and early embryogenesis is accomplished through the help of nuclear proteins such as transcription factors and chromatin-remodeling factors that act in the nucleus [ 1]. A family of nuclear transporters called karyopherins are the major players in the translocation of nuclear proteins through an active, energy-dependent nuclear import system. To date, seven members of karyopherin alpha (KPNA) have been identified in mammals; only KPNA7 is strictly expressed in oocytes and early embryos [ 2-4]. In mice, KPNA7 knockout lead to fetal lethality, sex imbalance and abnormalities of epigenetic modifications (e.g. down-regulation of histone H3K27me3) [ 3]. In livestock species, such as cattle and pigs, knockdown of KPNA7 significantly reduces blastocyst rate through inducing arrested embryonic development [ 2, 4]. In cattle, the expression of KPNA7 is high in germinal vesicle (GV) oocytes through 8-cell stage embryos but drops to barely detectable levels in morula and blastocyst stage embryos [ 2]. The sudden drop of mRNA levels during the 8-16 cell stages is coincident with the time of maternal-to-zygotic transition (MZT) in cattle. To date, little is known about the mechanistic control of tissue- and stage-specific expression of KPNA7.

DNA methylation at the 5-position of cytosine (5mC) largely occurs at CpG dinucleotides and is required for normal gametogenesis and embryogenesis in mammals [

                 5
              </a>]. In the early stages of oogenesis, the genome of embryonic germ cells is dynamically
           reprogrammed during cell differentiation and the differentially methylated regions
           begin to maintain the monoallelic expression of imprinted genes [<a href="#_ENREF_6">
              
                 6-8
              </a>]. Genes of developmental importance, such as germ cell-specific factors Nanog, Dazl,
           Pou5f1 and Sry, which control primordial germ cell development, are all regulated
           through DNA methylation-mediated mechanisms [<a href="#_ENREF_9">
              
                 9-11
              </a>]. Tissue-specific and differentially methylated regions are common in the mammalian
           genome and correspond to different cell types in an organism [<a href="#_ENREF_12">
              
                 12
              </a>]. Since DNA methylation profile is tissue-specific, it is reasonable to believe that
           DNA methylation, particularly, methylation in the CpG sites located in the proximal
           promoter surrounding the transcription start site (TSS), plays a role in controlling
           the expression of oocyte-specific maternal factors. </p>

Maternal effect genes are the major driving force to facilitate oocyte maturation, fertilization and embryonic genome activation [ 13]. However, after MZT, almost 90% of the maternal transcripts are degraded and the clearance of maternal transcripts is proved to be essential for normal embryonic development [ 14]. For example, in Xenopus laevis, abundance of the oocyte-specific maternal transcript c-mos is reduced quickly after fertilization, and introducing c-mos protein into 2-cell stage embryo led to development block [ 15]. This phenomenon was observed in the mouse and other species, which indicates that maternal transcript degradation is required for normal embryonic development [ 16]. Multiple negative regulatory mechanisms including mRNA deadenylation, interaction with RNA-binding proteins and miRNA-mediated degradation are involved in post-transcriptional degradation of maternal transcripts [ 17]. miRNAs such as miRNA-430 in zebrafish and miRNA-427 in Xenopus were shown to be present prior to embryonic genome activation and further studies revealed more evidence to support the role of these miRNAs in degradation of hundreds of maternal transcripts [

                 18-20
              </a>]. In cattle, a number of oocyte-specific maternal transcripts (e.g. <em>NPM2</em>, <em>NOBOX</em> and <em>FIGLA</em>) were shown to be targeted by miRNAs for their degradation [<a href="#_ENREF_21">
              
                 21-23
              </a>]. </p>

In the present study, we identified oocyte-specific differentially methylated CpG sites in the promoter region of bovine KPNA7 gene and demonstrated that KPNA7 mRNA is potentially targeted by miRNA-1296 for degradation. The results suggest distinctive controlling mechanisms for tissue- and stage-specific expression of bovine KPNA7 gene during oocyte and early embryonic development.

KPNA7 promoter is differentially methylated in bovine oocyte and somatic tissues

It has been generally believed that DNA hypermethylation at the proximal promoter can repress gene transcription by interfering with transcription initiation [

                 24
              </a>]. Therefore, differentially methylated promoter region of <em>KPNA7</em> gene may contribute to its oocyte-specific expression. Analysis of the genomic DNA
           sequence around the transcription start site (TSS) of <em>KPNA7</em> gene using an online algorithm (Methprimer) revealed multiple CpG sites including
           a CpG island containing 8 CpG sites (-221 to -114) located upstream of the TSS (Additional
           file 1. Figure 1). Using bisulfite conversion and subsequent DNA sequencing, the methylation
           status of 11 consecutive CpG sites including 8 within the CpG island and 3 located
           right before the TSS at the CpG island shore region were characterized. Three hypomethylated
           CpG sites (-149, -63 and -54) with high demethylation rates (60-70 %) were identified
           in the GV oocyte in comparison to 6 different somatic tissues including heart, lung,
           muscle, brain, intestine and spleen (Figure 2). The hypomethylation pattern observed
           in the 3 sites was found to exist only in the GV oocyte with no more than 20 % demethylation
           observed in any of the somatic tissues examined, which indicates a tissue-specific
           methylation pattern of these 3 CpG sites. </p>

Treatment with 5-Aza reintroduces expression of KPNA7 in CCL-22 cells

CCL-22 cells are derived from bovine kidney cells, which do not express KPNA7 naturally. 5-Aza inhibits activity of DNA methyltransferase 1 (DNMT1), an enzyme that maintains the status of DNA methylation. As cells divide, treatment of 5-Aza results in global demethylation of the cell genome, and thereby induces the expression of genes silenced by DNA methylation [ 25]. As shown in Figure 2A, KPNA7 expression was induced in the 5-Aza treated cells. Bisulfite sequencing of CCL-22 cells from the treatment (0.5 M) and the control groups showed demethylation of the KPNA7 proximal promoter in the treatment group, whereas in the control group, hypermethylation was observed (Figure 2B), which agrees with the RT-PCR results showing no expression of KPNA7 mRNA in the control group. Three oocyte-specific hypomethylated sites (-149, -63, and -54) are all methylated in the control group, and in the treatment group they underwent partial demethylation showing resemblance to the methylation status found in oocytes. These results indicate that DNA methylation in the proximal promoter of KPNA7 gene is critical for its tissue-specific expression, and the 3 oocyte-specific hypomethylated sites may play a primary role in controlling KPNA7 tissue-specificity.

Promoter demethylation does not activate KPNA7 expression after embryonic genome activation

As a maternal effect gene, KPNA7 is only expressed in oocyte and early embryos in which the expression level is high until it rapidly decreases after MZT (~16-cell stage) and does not increase again until the formation of primordial germ cells in late pregnancy [ 2]. Therefore, 16-cell and blastocyst stage embryos were used to test if silencing of KPNA7 expression was due to DNA methylation in the promoter region. Bisulfite sequencing and subsequent analysis showed that in 16-cell stage embryos, the KPNA7 proximal promoter is heavily hypomethylated (Figure 3). At the further developmental stage, when the embryonic genome is completely activated, the KPNA7 proximal promoter is still extremely hypomethylated. This pattern shows that DNA methylation of the CpG sites at the proximal promoter does not control KPNA7 expression in embryos after MZT, and thus silencing of KPNA7 expression in embryos after the 16-cell stage is likely due to other mechanisms.

miRNA-1296 is potentially involved in translational silencing of bovine KPNA7

To identify miRNAs that may target KPNA7, the KPNA7 cDNA sequence (GenBank accession No. FJ754641) was uploaded to the online algorithm “Microinspector” ( http://bioinfo.uni-plovdiv.bg/microinspector/) to predict miRNA binding sites. Four miRNA-1296 recognition elements in the coding region of KPNA7 mRNA were predicted (Figure 4). Co-transfection of expression constructs harboring miRNA-1296 and KPNA7 showed a reduction of KPNA7 protein expression in HEK293 cells compared to the cells transfected with KPNA7 expression construct alone (Figure 5A). This experiment was repeated three times and quantitative analysis of western blot data showed a significant reduction of KPNA7 protein in the co-transfection group (Figure 5B). The results suggest that miRNA-1296 may play a role in the regulation of bovine KPNA7 expression at the post-transcriptional level. RT-qPCR analysis showed that miRNA-1296 expression reaches its peak level in the 8-cell stage embryo, which is coincident with the start of decliningof KPNA7 expression (Figure 6). The data supports our hypothesis that miRNA-1296 acts as a functional physiological regulator for KPNA7 expression during early embryogenesis.

Tissue-specific deferential methylation has become an important aspect in epigenetic-related gene expression studies [ 26, 27]. Comparisons between oocyte and sperm, developmental germ cell stages, and different embryonic stages showed stage- or germ cell- specific differentially methylated regions [ 28, 29]. In this study, we demonstrated that methylation of 3 CpG sites (-149, -63 and -54) in the promoter region controls tissue-specific expression of bovine KPNA7 gene. Two of the differentially methylated sites are located in the CpG island shore region (-63 and -54). The role of CpG island shore regions in controlling gene expression has been recently demonstrated [ 30, 31].

Control of gene expression by specific CpG sites was observed in a previous study in prostate cancer cells [ 32]. When treated with a minimal concentration of 5-Aza, one CpG site was hypersensitive to the challenge and methylation of this single site led to silencing of PMP24 gene. In the present study, we observed that demethylation of CpG sites tends to spread from the TSS towards the upstream positions. Two sites (-63 and -54) closest to the TSS had the highest demethylation level than did the sites located upstream, suggesting a primary role of these 2 sites in controlling the expression of KPNA7 gene.

After fertilization, the paternal genome undergoes spontaneous global demethylation before first cleavage but the maternal genome retains its methylation status until the first cleavage event in which demethylation occurs passively with each cell division [ 33]. In cattle, the embryonic genome is mostly activated by the 16-cell stage and is completely activated in the blastocyst stage embryo. The methylation status of the 5’ terminal region near the TSS of developmentally important genes has been surveyed and all the genes, including Oct4, Sox2, Nanog, Rex1 and Fgf4, experienced demethylation after fertilization and the expression of these genes were not accompanied by the demethylation of their promoter regions [ 34]. Therefore, the dynamic methylation changes in early embryonic development, especially during MZT, might not contribute to activation of gene transcription. In this case, the reduction of KPNA7 mRNA level is explained by inactivation of transcriptional activity, however, on the other hand, rapid mRNA degradation might also be a reason for diminishment of the KPNA7 transcript.

With strong potential to form a complementation duplex between miRNA-1296 and KPNA7 mRNA, the functional role of miR-1296 in regulation of KPNA7 expression was investigated. The predicted miRNA binding sites were located in the coding region rather than the 3’UTR of KPNA7 mRNA. The classic miRNA-mediated post-transcriptional regulation of mRNAs has been believed to be confined to the 3’UTR region of the transcripts [ 35]. However, new studies have demonstrated the existence of many naturally occurring alternative binding regions of miRNA in mammalian cells [ 36, 37]. During embryogenesis, miR-134, miR-296 and miR-470 target the coding regions of transcription factors Nanog, Oct4 and Sox2 in various combinations, leading to transcriptional and morphological changes in mouse embryonic stem cells [ 36]. In bovine species, Nanog, Oct4 and Sox2 are all oocyte-specific maternal factors that govern early embryonic development by regulating the pluripotency of blastomeres [ 38, 39]. Thus, miRNA targeting the coding regions of developmentally important factors might be a characteristic feature in post-transcriptional regulation of maternal effect factors.

Targets of miRNA-1296 have been studied and shown to be highly involved in essential DNA replication [ 40]. miRNA-1296 targets MCM2 mRNA in prostate cancer cells and over expression of miRNA-1296 results in a significant decrease in MCM2 mRNA, protein, and S-phase of the cell cycle. MCM2 is an essential DNA replication factor that is highly expressed in cancer cells as well as in the oocyte and is highly involved in resumption of meiosis in mammalian oocytes [ 41]. The involvement of miRNA-1296 in regulating the expression of KPNA7 supports a new role of this miRNA in the control of oocyte and early embryonic development.

In this study, we found that the oocyte restricted expression of bovine KPNA7 is regulated by DNA methylation at the proximal promoter and demethylation of 3 CpG sites is closely related to tissue-specific expression of this gene. We also provided evidence showing that miRNA-1296 is potentially involved in translational silencing of bovine KPNA7 through binding sites in the coding region of KPNA7 mRNA. This study combined two aspects of epigenetic regulation of gene expression and discovered distinctive controlling mechanisms for tissue- and stage-specific expression of bovine KPNA7 gene.

Sample collection

Bovine tissue samples including heart, lung, muscle, brain, intestine and spleen were collected at a local abattoir. Bovine GV oocytes and early stage embryos were purchased from Bomed, Inc. (Madison, WI). All samples were frozen in liquid nitrogen and stored at -80 ^◦C until use.

Plasmid construction

The open reading frame (ORF) of bovine KPNA7 cDNA was PCR amplified from a KPNA7 expression plasmid [

                 2
              </a>] and cloned into pcDNA3.1/myc-His vector (Invitrogen, Carlsbad, CA) using a forward
           primer containing a Kozak sequence and BamHI site and a reverse primer containing
           a XhoI site (Additional file 1, Figure 1). The plasmid designed to express the bovine miRNA-1296 was prepared by PCR amplification
           of a 291 bp genomic fragment containing the pre-miRNA-1296 followed by cloning into pcDNA3.1 vector using a forward primer containing a BamHI site and a reverse
           primer containing a PmeI site (Additional file 1, Figure 1). Both constructs were sequenced to ensure that no mutations were introduced during
           PCR amplification. </p>

Bisulfite sequencing

DNA samples isolated from oocytes/embryos or somatic tissues were treated by bisulfite following the manufacturer’s instructions of the EZ DNA Methylation-Direct™ kit (Zymo Research, Irvine, CA). Primers (Additional file 1, Figure 1) were designed using Methprimer online program and were used in a 25-µl PCR reaction for the first round of 40 cycles. Cycling conditions were as follows: 95°C for 9 min followed by 40 cycles of 95 °C for 30 s, 54 °C for 30 s, 72 °C for 30 s and a final extension of 5 min at 72 °C. Nested PCR of 35 cycles was performed using the PCR product as a template in a higher annealing temperature at 58 °C and a shorter denaturation time of 5 min at 95 °C. The DNA regions of CpG sites were amplified, and three independent PCR reactions were performed. The PCR products were purified, pooled together and cloned into pGEM-T Easy vector (Promega). After verification, 10 clones for each DNA sample were sequenced, and the sequences were analyzed using the online tool QUMA (http://quma.cdb.riken.jp/).

Cell culture

HEK293 cells were cultured in DMEM (Invitrogen, Carlsbad, CA) containing 10 % FBS. For transient transfection, Xtremegene 9 (Roche Applied Science, Indianapolis, IN) was used according to manufacturer’s instructions. Following transfection, cells were incubated for 24 h before harvest for western blot analysis. CCL22 cells were cultured in DMEM containing 10 % HS. 5-aza-2-deoxycytidine (5-Aza) was added to the culture medium with a final concentration of 0.5 µM in 6-well plates (Corning Inc., Corning, NY) seeded with cells 24 h before the treatment. Treatment continued for 3 days with fresh 5-Aza changed every 24 h. After 3 days, cells were harvested and stored at -80 °C until use.

Western blot analysis

Electrophoresis and transfer were performed according to a previous study with minor modifications [ 42]. HEK293 cell were harvested with Pierce IP Lysis Buffer (Thermo Fisher Scientific, Waltham, MA), and 10 μl of cell lysate were mixed with an equal volume of Laemmli sample buffer (Bio-Rad Laboratories, Hercules, CA). Protein samples (15 μg/each) were separated on a 4-20% gradient ready gel (Bio-Rad) and transferred onto a Immobilon-FL PVDF membrane (Millipore, Billerica, MA). Following transfer and blocking in 5 % nonfat dry milk in PBS containing 0.1% Tween-20 (PBST) for one hour, the membrane was incubated in anti-Myc antibody (Sigma-Aldrich, St. Louis, MO) diluted 1:1000 and anti-ACTB antibody (GenScript, Piscataway, NJ) diluted 1:1000 in blocking buffer overnight at 4 °C. After 3 washes, two secondary antibodies IRDye 800CW goat anti-rabbit and IRDye 680LT goat anti-mouse (Li-COR, Lincoln, NE) were added to the blocking buffer and incubated for 20 min. Detection of protein was performed following the instructions of the Odyssey system (Li-COR, Lincoln, NE). ImageJ software was used to quantify the protein bands. Abundance of KPNA7 protein was normalized relative to the abundance of ACTB protein.

Quantitative real-time PCR (RT-qPCR)

cDNA from oocyte and embryo samples (n = 3 pools of five each) was prepared by lysing the samples in 1× miScript RT buffer containing 0.5 % NP-40 at 95 °C for 5 min followed by addition of miScript reverse transcriptase mix (Qiagen, Valencia, CA) and incubation at 37 °C for 60 min. The cDNA was then used for determination of relative amount of miR-1296 by RT-qPCR using the miRNA-1296 specific primer and the miScript universal primer (Qiagen, Valencia, CA). Bovine miRNA-125b was used as an endogenous control as this miRNA is expressed consistently in preimplantation embryos [ 43]. RT-qPCR analysis was performed on the Bio-Rad CFX96 system. The iQ™ SYBR Green Supermix (Bio-Rad, Hercules, CA) was used in 20 μl reaction volumes containing 100 nM of each primer and 5 μl of diluted cDNA. Cycling parameters were 95 °C for 15 min, and then 40 cycles of 95 °C for 15 s, 55 °C for 30 s and 70 °C for 30 s. Standard curves for the target and control miRNA were constructed using 10-fold serial dilution of a pooled cDNA sample.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Funding

This work was supported by Agriculture and Food Research Initiative Competitive Grant no. 2016-67015-24919 from the USDA National Institute of Food and Agriculture and funds from the West Virginia Agricultural and Forestry Experiment Station (Hatch project No. 427).

Authors’ contributions

LW performed most of the experiments including methylation analysis, preparation of constructs and cell transfection. LW also drafted the manuscript. JMH and LF helped in sample collection and gene expression analysis. GWS and JY designed the study and supervised the experimental work. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

1. Itman C, Miyamoto Y, Young J, Jans D, Loveland K: Nucleocytoplasmic transport as a driver of mammalian gametogenesis. In: Seminars in cell & developmental biology: 2009. Elsevier: 607-619.

2. Tejomurtula J, Lee K, Tripurani SK, Smith GW, Yao J: Role of Importin Alpha8, a New Member of the Importin Alpha Family of Nuclear Transport Proteins, in Early Embryonic Development in Cattle. Biology of reproduction 2009, 81(000268277300012):333-342.

3. Hu J, Wang F, Yuan Y, Zhu X, Wang Y, Zhang Y, Kou Z, Wang S, Gao S: Novel importin-alpha family member Kpna7 is required for normal fertility and fecundity in the mouse. Journal of Biological Chemistry 2010, 285(20699224):33113-33122.

4. Wang X, Park KE, Koser S, Liu S, Magnani L, Cabot RA: KPNA7, an oocyte-and embryo-specific karyopherin α subtype, is required for porcine embryo development. Reproduction, Fertility and Development 2011.

5. Messerschmidt DM: Should I stay or should I go: Protection and maintenance of DNA methylation at imprinted genes. In: Epigenetics. vol. 7; 2012.

6. Panning B, Jaenisch R: DNA hypomethylation can activate Xist expression and silence X-linked genes. Genes & Development 1996, 10(16):1991-2002.

7. Kass SU, Landsberger N, Wolffe AP: DNA methylation directs a time-dependent repression of transcription initiation. Current Biology 1997, 7(3):157-165.

8. Maeda C, Sato S, Hattori N, Tanaka S, Yagi S, Shiota K: DNA hypomethylation circuit of the mouse oocyte-specific histone H1foo gene in female germ cell lineage. Biology of reproduction 2008, 78(18184919):816-821.

9. Nishino K, Hattori N, Tanaka S, Shiota K: DNA methylation-mediated control of Sry gene expression in mouse gonadal development. Journal of Biological Chemistry 2004, 279(21):22306-22313.

10. Hattori N, Nishino K, Ko Y, Hattori N, Ohgane J, Tanaka S, Shiota K: Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. Journal of Biological Chemistry 2004, 279(17):17063-17069.

11. Maatouk DM, Kellam LD, Mann MRW, Lei H, Li E, Bartolomei MS, Resnick JL: DNA methylation is a primary mechanism for silencing postmigratory primordial germ cell genes in both germ cell and somatic cell lineages. Development 2006, 133(17):3411-3418.

12. Shiota K: DNA methylation profiles of CpG islands for cellular differentiation and development in mammals. Cytogenetic and genome research 2004, 105(2-4):325-334.

13. Li L, Zheng P, Dean J: Maternal control of early mouse development. Development 2010, 137(6):859-870.

14. Paynton BV, Rempel R, Bachvarova R: Changes in state of adenylation and time course of degradation of maternal mRNAs during oocyte maturation and early embryonic development in the mouse. Developmental biology 1988, 129(2):304-314.

15. Sagata N, Watanabe N, Woude GFV, Ikawa Y: The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs. 1989.

16. Alizadeh Z, Kageyama S, Aoki F: Degradation of maternal mRNA in mouse embryos: selective degradation of specific mRNAs after fertilization. Molecular reproduction and development 2005, 72(16094646):281-290.

17. Bettegowda A, Smith GW: Mechanisms of maternal mRNA regulation: implications for mammalian early embryonic development. Frontiers in bioscience : a journal and virtual library 2007, 12:3713-3726.

18. Bazzini AA, Lee MT, Giraldez AJ: Ribosome profiling shows that miR-430 reduces translation before causing mRNA decay in zebrafish. Science (New York, NY) 2012, 336(22422859):233-237.

19. Lund E, Liu M, Hartley RS, Sheets MD, Dahlberg JE: Deadenylation of maternal mRNAs mediated by miR-427 in Xenopus laevis embryos. RNA (New York, NY) 2009, 15(19854872):2351-2363.

20. Giraldez AJ, Mishima Y, Rihel J, Grocock RJ, Van Dongen S, Inoue K, Enright AJ, Schier AF: Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs. Science (New York, NY) 2006, 312(16484454):75-79.

21. Tripurani SK, Lee K, Wee G, Smith GW, Yao J: MicroRNA-196a regulates bovine newborn ovary homeobox gene (NOBOX) expression during early embryogenesis. BMC Developmental Biology 2011, 11(21548929):25.

22. Tripurani SK, Wee G, Lee K, Smith GW, Wang L, Jianboyao: MicroRNA-212 post-transcriptionally regulates oocyte-specific basic-helix-loop-helix transcription factor, factor in the germline alpha (FIGLA), during bovine early embryogenesis. PLoS ONE 2013, 8(24086699):e76114.

23. Lingenfelter BM, Tripurani SK, Tejomurtula J, Smith GW, Yao J: Molecular cloning and expression of bovine nucleoplasmin 2 (NPM2): a maternal effect gene regulated by miR-181a. Reprod Biol Endocrinol 2011, 9:40.

24. Borgel J, Guibert S, Li Y, Chiba H, Schübeler D, Sasaki H, Forné T, Weber M: Targets and dynamics of promoter DNA methylation during early mouse development. Nature Genetics 2010, 42(21057502):1093-1100.

25. Jones PA: Effects of 5-azacytidine and its 2′-deoxyderivative on cell differentiation and DNA methylation. Pharmacology & therapeutics 1985, 28(1):17-27.

26. Song F, Mahmood S, Ghosh S, Liang P, Smiraglia DJ, Nagase H, Held WA: Tissue specific differentially methylated regions (TDMR): Changes in DNA methylation during development. Genomics 2009, 93(18952162):130-139.

27. Canastar A, Logel J, Graw S, Finlay-Schultz J, Osborne C, Palionyte M, Drebing C, Plehaty M, Wilson L, Eyeson R et al: Promoter Methylation and Tissue-Specific Transcription of the α7 Nicotinic Receptor Gene, CHRNA7. Journal of Molecular Neuroscience 2012, 47(2):389-400.

28. Kobayashi H, Sakurai T, Imai M, Takahashi N, Fukuda A, Yayoi O, Sato S, Nakabayashi K, Hata K, Sotomaru Y: Contribution of intragenic DNA methylation in mouse gametic DNA methylomes to establish oocyte-specific heritable marks. PLoS Genetics 2012, 8(1):e1002440.

29. Smallwood SA, Tomizawa S, Krueger F, Ruf N, Carli N, Segonds-Pichon A, Sato S, Hata K, Andrews SR, Kelsey G: Dynamic CpG island methylation landscape in oocytes and preimplantation embryos. Nature Publishing Group 2011, 43(8):811-814.

30. Rao X, Evans J, Chae H, Pilrose J, Kim S, Yan P, Huang R, Lai H, Lin H, Liu Y: CpG island shore methylation regulates caveolin-1 expression in breast cancer. Oncogene 2013, 32(38):4519-4528.

31. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M: Genome-wide methylation analysis of human colon cancer reveals similar hypo-and hypermethylation at conserved tissue-specific CpG island shores. Nature Genetics 2009, 41(2):178.

32. Zhang X, Wu M, Xiao H, Lee M, Levin L, Leung Y, Ho S: Methylation of a single intronic CpG mediates expression silencing of the PMP24 gene in prostate cancer. The Prostate 2010, 70(20054818):765-776.

33. Santos F, Hendrich B, Reik W, Dean W: Dynamic reprogramming of DNA methylation in the early mouse embryo. Developmental biology 2002, 241(11784103):172-182.

34. Lan J, Hua S, Zhang H, Song Y, Liu J, Zhang Y: Methylation patterns in 5'terminal regions of pluripotency-related genes in bovine in vitro fertilized and cloned embryos. Journal of Genetics and Genomics 2010, 37(10301776905780968566related:drxlwIND944J):297-304.

35. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(14744438):281-297.

36. Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I: MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008, 455(7216):1124-1128.

37. Mandke P, Wyatt N, Fraser J, Bates B, Berberich SJ, Markey MP: MicroRNA-34a Modulates MDM4 Expression via a Target Site in the Open Reading Frame. PLoS ONE 2012, 7(22870278):e42034.

38. Goissis MD, Cibelli JB: Functional Characterization of SOX2 in Bovine Preimplantation Embryos. Biology of reproduction 2014, 90(24389873):30.

39. Kurosaka S, Eckardt S, McLaughlin KJ: Pluripotent lineage definition in bovine embryos by Oct4 transcript localization. Biol Reprod 2004, 71(15229144):1578-1582.

40. Guiguen Y, Baroiller JF, Ricordel MJ, Iseki K, McMeel OM, Martin SA, Fostier A: Involvement of estrogens in the process of sex differentiation in two fish species: the rainbow trout (Oncorhynchus mykiss) and a tilapia (Oreochromis niloticus). Molecular reproduction and development 1999, 54(10471475):154-162.

41. Swiech L, Kisiel K, Czolowska R, Zientarski M, Borsuk E: Accumulation and dynamics of proteins of the MCM family during mouse oogenesis and the first embryonic cell cycle. International Journal of Developmental Biology 2007, 51(4):283.

42. Wang L, Tripurani SK, Wanna W, Rexroad CE, Yao J: Cloning and characterization of a novel oocyte-specific gene encoding an F-Box protein in rainbow trout (Oncorhynchus mykiss). Reproductive Biology and Endocrinology 2013, 11:86.

43. Byrne MJ, Warner CM: MicroRNA expression in preimplantation mouse embryos from Ped gene positive compared to Ped gene negative mice. Journal of assisted reproduction and genetics 2008, 25(5):205-214.

Additional file 1: Table 1. List of primers used in this study.

Additional file 2: Figure 1. Identification of CpG sites in the proximal promoter of bovine KPNA7 gene. Analysis of DNA sequence around the transcription start site (TSS) of bovine KPNA7 gene using Methprimer (http://www.urogene.org/cgi-bin/methprimer2/MethPrimer.cgi) revealed multiple CpG sites including a CpG island containing 8 CpG sites (-221 to -114) located upstream of the TSS.

Download PDF

Journal Publication

published 02 Dec, 2019

Read the published version in BMC Developmental Biology →

Review #3 received at journal
17 Jul, 2019
Editorial decision: Major revision
17 Jul, 2019
Reviewer #3 agreed at journal
03 Jul, 2019
Review #2 received at journal
03 Jun, 2019
Review #1 received at journal
03 Jun, 2019
Reviewer #2 agreed at journal
29 May, 2019
Reviewers invited by journal
28 May, 2019
Reviewer #1 agreed at journal
28 May, 2019
Submission checks completed at journal
24 May, 2019
Editor invited by journal
24 May, 2019
First submitted to journal
22 May, 2019
Editor assigned by journal
22 May, 2019

You are reading this older preprint version

Read the latest preprint version →

DNA methylation and miRNA-1296 act in concert to mediate spatiotemporal expression of KPNA7 during bovine oocyte and early embryonic development

Status:

Journal Publication

Version 1

Abstract

Figures

Background

Results

KPNA7 promoter is differentially methylated in bovine oocyte and somatic tissues

Treatment with 5-Aza reintroduces expression of KPNA7 in CCL-22 cells

Promoter demethylation does not activate KPNA7 expression after embryonic genome activation

miRNA-1296 is potentially involved in translational silencing of bovine KPNA7

Discussion

Conclusions

Methods

Sample collection

Plasmid construction

Bisulfite sequencing

Cell culture

Western blot analysis

Quantitative real-time PCR (RT-qPCR)

Declarations

Availability of data and materials

Funding

Authors’ contributions

Competing interests

References

Additional material legends

Supplementary Files

Status:

Journal Publication

Version 1